WallStreetZenWallStreetZen

NASDAQ: DH
Definitive Healthcare Corp Stock Forecast, Predictions & Price Target

Analyst price target for DH

Based on 6 analysts offering 12 month price targets for Definitive Healthcare Corp.
Min Forecast
$15.00+45.91%
Avg Forecast
$19.00+84.82%
Max Forecast
$26.00+152.92%

Should I buy or sell DH stock?

Based on 6 analysts offering ratings for Definitive Healthcare Corp.
Buy
Strong Buy
1 analysts 16.67%
Buy
1 analysts 16.67%
Hold
4 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DH stock forecasts and price targets.

DH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Anonymous
Morgan Stanley
Strong BuyMaintains$17.00+65.37%2023-02-28
Credit Suisse
Bottom 9%
9
HoldMaintains$15.00+45.91%2023-02-24
Needham
Top 21%
80
BuyReiterates$15.00+45.91%2023-02-24
Morgan Stanley
Bottom 20%
20
Strong BuyMaintains$18.00+75.10%2023-01-06
Goldman Sachs
Top 26%
75
HoldMaintains$17.00+65.37%2022-11-07
Barclays
Bottom 9%
9
HoldMaintains$23.00+123.74%2022-08-08
Deutsche Bank
Top 12%
89
HoldMaintains$26.00+152.92%2022-04-05

1 of 1

Forecast return on equity

Is DH forecast to generate an efficient return?
Company
7.66%
Industry
7.29%
Market
51.53%
DH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DH forecast to generate an efficient return on assets?
Company
3.44%
Industry
5.14%
DH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DH earnings per share forecast

What is DH's earnings per share in the next 2 years based on estimates from 4 analysts?
Avg 1 year Forecast
$0.14
Avg 2 year Forecast
$0.44

DH revenue forecast

What is DH's revenue in the next 2 years based on estimates from 6 analysts?
Avg 1 year Forecast
$279.8M+25.65%
Avg 2 year Forecast
$347.8M+56.19%
DH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DH revenue growth forecast

How is DH forecast to perform vs Health Information Services companies and vs the US market?
Company
25.65%
Industry
19.9%
Market
25.31%
DH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DH vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
DH$10.28$19.00+84.82%Buy
PHR$31.50$37.92+20.37%Strong Buy
SDGR$25.57$58.60+129.17%Buy
MDRX$13.15$20.90+58.94%Hold
AGTI$15.91$20.71+30.19%Buy

Definitive Healthcare Stock Forecast FAQ

Is Definitive Healthcare Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: DH) stock is to Buy DH stock.

Out of 6 analysts, 1 (16.67%) are recommending DH as a Strong Buy, 1 (16.67%) are recommending DH as a Buy, 4 (66.67%) are recommending DH as a Hold, 0 (0%) are recommending DH as a Sell, and 0 (0%) are recommending DH as a Strong Sell.

If you're new to stock investing, here's how to buy Definitive Healthcare stock.

What is DH's earnings growth forecast for 2023-2024?

(NASDAQ: DH) Definitive Healthcare's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 86.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 77.86%.

Definitive Healthcare's earnings in 2023 is -$6,037,000.On average, 4 Wall Street analysts forecast DH's earnings for 2023 to be $23,217,988, with the lowest DH earnings forecast at $14,925,850, and the highest DH earnings forecast at $39,802,266.

In 2024, DH is forecast to generate $72,970,821 in earnings, with the lowest earnings forecast at $72,970,821 and the highest earnings forecast at $72,970,821.

What is DH's revenue growth forecast for 2023-2024?

(NASDAQ: DH) Definitive Healthcare's forecast annual revenue growth rate of 25.65% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 19.9%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 25.31%.

Definitive Healthcare's revenue in 2023 is $222,653,000.On average, 6 Wall Street analysts forecast DH's revenue for 2023 to be $46,396,671,983, with the lowest DH revenue forecast at $45,503,940,330, and the highest DH revenue forecast at $47,117,590,521.

In 2024, DH is forecast to generate $57,674,643,986 in revenue, with the lowest revenue forecast at $55,222,326,887 and the highest revenue forecast at $59,476,194,040.

What is DH's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: DH) forecast ROA is 3.44%, which is lower than the forecast US Health Information Services industry average of 5.14%.

What is DH's Price Target?

According to 6 Wall Street analysts that have issued a 1 year DH price target, the average DH price target is $19.00, with the highest DH stock price forecast at $26.00 and the lowest DH stock price forecast at $15.00.

On average, Wall Street analysts predict that Definitive Healthcare's share price could reach $19.00 by Feb 24, 2024. The average Definitive Healthcare stock price prediction forecasts a potential upside of 84.82% from the current DH share price of $10.28.

What is DH's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: DH) Definitive Healthcare's current Earnings Per Share (EPS) is -$0.06. On average, analysts forecast that DH's EPS will be $0.14 for 2023, with the lowest EPS forecast at $0.09, and the highest EPS forecast at $0.24. In 2024, DH's EPS is forecast to hit $0.44 (min: $0.44, max: $0.44).

What is DH's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: DH) forecast ROE is 7.66%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.